Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

KRX:185750 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,088,343	1,178,982	1,665,713	1,001,820	1,312,265	2,572,969
Market Cap Growth	-26.03%	-29.22%	66.27%	-23.66%	-49.00%	145.08%
Enterprise Value	1,078,813	1,062,300	1,643,506	1,090,150	1,317,515	2,555,288
Last Close Price	82600.00	89000.00	123206.25	72988.82	92946.29	179136.40
PE Ratio	17.87	10.81	7.84	12.38	30.72	28.08
Forward PE	17.69	14.47	18.84	14.29	14.96	28.32
PS Ratio	0.65	0.74	1.00	0.67	0.98	1.98
PB Ratio	1.19	1.32	2.04	1.61	2.32	4.67
P/TBV Ratio	1.31	1.44	2.18	1.68	2.41	4.83
P/FCF Ratio	-	45.67	6.02	43.87	-	35.89
P/OCF Ratio	513.73	18.34	5.24	14.79	101.70	24.66
PEG Ratio	-	1.08	0.45	0.46	8.17	8.17
EV/Sales Ratio	0.65	0.67	0.98	0.73	0.98	1.96
EV/EBITDA Ratio	9.64	7.63	5.80	7.60	10.78	17.30
EV/EBIT Ratio	15.66	10.68	6.67	9.92	13.90	20.62
EV/FCF Ratio	-25.07	41.15	5.93	47.74	-	35.65
Debt / Equity Ratio	0.23	0.21	0.27	0.38	0.42	0.25
Debt / EBITDA Ratio	1.90	1.35	0.77	1.64	1.94	0.92
Debt / FCF Ratio	-	7.29	0.79	10.32	-	1.90
Asset Turnover	1.12	1.11	1.32	1.37	1.35	1.49
Inventory Turnover	3.10	3.43	3.79	3.82	4.13	4.87
Quick Ratio	1.42	1.63	1.32	1.16	1.30	1.19
Current Ratio	2.46	2.61	1.85	1.91	2.08	1.87
Return on Equity (ROE)	6.82%	13.02%	29.73%	13.47%	7.58%	17.61%
Return on Assets (ROA)	2.90%	4.35%	12.20%	6.33%	5.94%	8.86%
Return on Capital (ROIC)	3.88%	5.87%	16.29%	8.28%	7.95%	12.10%
Return on Capital Employed (ROCE)	6.20%	9.10%	27.70%	14.60%	13.00%	19.80%
Earnings Yield	5.60%	9.25%	12.76%	8.08%	3.26%	3.56%
FCF Yield	-3.95%	2.19%	16.63%	2.28%	-2.69%	2.79%
Dividend Yield	1.33%	1.24%	-	-	-	-
Payout Ratio	22.67%	12.22%	5.46%	13.88%	25.30%	10.12%
Buyback Yield / Dilution	5.33%	5.20%	-3.79%	1.77%	0.73%	0.06%
Total Shareholder Return	6.69%	6.43%	-3.79%	1.77%	0.73%	0.06%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.